The University of Chicago Header Logo

Connection

Mark Lingen to Radiopharmaceuticals

Back to Details
This is a "connection" page, showing publications Mark Lingen has written about Radiopharmaceuticals.
Mark Lingen
Connection Strength
0.102
Radiopharmaceuticals
  1. Genetic profiling of advanced radioactive iodine-resistant differentiated thyroid cancer and correlation with axitinib efficacy. Cancer Lett. 2015 Apr 10; 359(2):269-74.
    View in: PubMed
    Score: 0.102
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.